Moirai Orthopaedics, L.L.C., an orthopaedic implant development company based in Metairie, Louisiana, is pleased to announce it has received approval from the US Food and Drug Administration for its Investigational Device Exemption (IDE) application to initiate clinical study of the company's Pyrocarbon Implant Replacement (PIR) System.
from The Medical News http://ift.tt/1yuaXy9
from The Medical News http://ift.tt/1yuaXy9
No comments:
Post a Comment